Kai-Friedrich Niermann
Cannabis Blog & Reports
- Full Cannabis Industry Consulting
- Compliance
- Regulation
- Commerce
- Advocacy
- Commercial Criminal Law
- Legal Opinions
- Second Opinion
- Medical, Recreational, CBD and Hemp
Lifelong expertise
Vita
Kai-Friedrich Niermann is an attorney and the founder of KFN+ Law Office. His practice focuses on cannabis and business law. He advises companies and associations at the intersection of business practice and the legal framework governing medical cannabis, industrial hemp, and CBD.
Through KFN+, he supports companies from their founding and contract drafting, through the development and marketing of their products, to providing legal counsel for day-to-day business operations. This includes regulatory issues related to cultivation, production, import, and distribution, as well as the structuring of international business relationships. When necessary, his work also includes representation in matters of white-collar crime.
His clients include companies in the medical cannabis and CBD sectors, as well as companies and growers’ associations in the non-medical cannabis sector. As legal counsel to the European Industrial Hemp Association (EIHA), he focuses in particular on the European regulatory framework for industrial hemp and CBD, as well as novel food authorization procedures.
His advice combines legal analysis with an understanding of business models, economic interests, and the unique characteristics of an internationally oriented industry. The focus is on providing clear answers to complex legal questions and practical solutions for business implementation.
On his blog, canna-biz.legal, Kai-Friedrich Niermann analyzes and comments on developments in German and European cannabis law. In addition, he publishes articles in legal journals and industry media such as Krautinvest and BusinessCann, and regularly speaks at international conferences.
Born in Löhne, Westphalia, in 1972, he studied law at the universities of Marburg, Adelaide (Australia), and Cologne. He served as a press officer at the German Bundestag’s Press Center (1999–2000), followed by a legal clerkship culminating in the Second State Examination (bar exam), with placements at the Berlin Regional Court and the Berlin Public Prosecutor’s Office, as well as at the Berlin Office for the Protection of the Constitution and the Consulate General of Hong Kong.
Global Charing of knowledge
Presentations and Panels
2025
- ICBC Berlin – Moderator of the Panel “European Cannabis Pilot Projects”
- Reggae im Hanffeld – Q+A zum KCanG
- HAMCAN – Open Discussion, CanG Law, what do you like to know? – mit RA Jan Rasmus und Andreas Alberts
- CB Expo- Co Moderator of the Panel “Recreational Cannabis masquerading as Medical, and the E-Commercification of Prescription Medicine in Europe”
- Talman House – London – Panel with Peter Homberg and Gaspar Friskovec – “European Cannabis Industry Market Report”
- Deutsche AIDS-Hilfe – Entkriminalisierung oder Legalisierung? Webinar mit Prof. Dr. Stöver, Prof. Dr. Böllinger und Dirk Schäffer
- LEAP Mitgliederversammlung 2025 - Versammlungsleitung
2024
Spreading of the idea
Publications
- Prohibition Partners
- Leafly.de
- Krautinvest - Novel Food Antrag der EIHA
- Werben & Verkaufen
- Hemp Industry Daily
- Cannabis Law Report
- Froriep Lexcast, with Daniel Haymann abouCBD extracts as a narcotic in the EU
- CBD: A Comparison of EU and US Paths to Market (INCBA Webinar 01/30/2020)
- Zeitschrift für Lebensmittelrecht (ZLR), Niermann/Schulte, ZLR 2021, 336-353, Die Verkehrsfähigkeit von hanfhaltigen Lebensmitteln, Nutzhanfblüten und Nutzhanfblättern im Lichte der neueren Rechtsprechung des EuGHs
- Cannabis ist längst Teil des Alltags – die Kriminalisierung muss weg, in „Welt“ am 25.10.2021
- Der Hype um Cannabidiol und Hanf - auf der Suche nach klaren Regeln und realistischen Richtwerten, Zeitschrift für Phytotherapie 2021, 320 ff.
- Legalisierung und Lizensierung - Krautinvest 2022
- Die verhinderte Legalisierung - Krautinvest 2023
- CBD als Lebensmittel, Arzneimittel oder Kosmetikum – eine rechtliche und wissenschaftliche Einschätzung - Niermann/Beitzke/Nahler/Kruse, Zeitschrift für gesamte Lebensmittelrecht 1/24
- Cannabis ist nicht gleich Cannabis – aber wann ist Cannabis dann Cannabis? – Krautinvest 2024
- Die Verkehrs- und Vertriebsfähigkeit von Cannabissamen und Cannabis-Stecklingen nach dem neuen Konsumcannabisgesetz (KCanG) – Zeitschrift für Vertriebsrecht 2024
- PharmR 8/2026: Telemedizin und die Verschreibung von Cannabis – eine aktuelle Übersicht der Rechtsprechung und aktuellen Entwicklungen
- ZVertriebsR 09/2026: GMP-Washing und medizinisches Cannabis Qualitätsentstehung, Lieferkettenrisiken und die wettbewerbsrechtliche Zulässigkeit GMP-bezogener Qualitätsclaims